Nonreplacement therapy for hemophilia in low-income countries: experience from a prospective study in Ivory Coast.

Lambert, Catherine; Meité, N'Dogomo; Kouassi, Gustave Koffi; Dohoma, Alexis Silué; Bognini Akou, Sara Adélaide; Sanogo, Ibrahima; Hermans, Cedric

Lambert, Catherine; Meité, N'Dogomo; Kouassi, Gustave Koffi; Dohoma, Alexis Silué; Bognini Akou, Sara Adélaide; Sanogo, Ibrahima; Hermans, Cedric.

Afiliação

Lambert C; Hemostasis and Thrombosis Unit, Division of Haematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Meité N; Division of Clinical Haematology, Centre Hospitalier Universitaire de Yopougon, Abidjan, Ivory Coast.
Kouassi GK; Division of Clinical Haematology, Centre Hospitalier Universitaire de Yopougon, Abidjan, Ivory Coast.
Dohoma AS; Division of Clinical Haematology, Centre Hospitalier Universitaire de Yopougon, Abidjan, Ivory Coast.
Bognini Akou SA; Division of Clinical Haematology, Centre Hospitalier Universitaire de Yopougon, Abidjan, Ivory Coast.
Sanogo I; Division of Clinical Haematology, Centre Hospitalier Universitaire de Yopougon, Abidjan, Ivory Coast.
Hermans C; Hemostasis and Thrombosis Unit, Division of Haematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

Res Pract Thromb Haemost ; 7(1): 100033, 2023 Jan.

Article em En | MEDLINE | ID: mdl-36785756

Palavras-chave

Ivory Coast; emicizumab; hemophilia A; innovative therapies; low-income countries

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Aspecto: Determinantes_sociais_saude / Equity_inequality / Patient_preference Idioma: En Revista: Res Pract Thromb Haemost Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Bélgica

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google